World's Best Scientists 2026 revealed!
Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 109 524 485 4 4 682 38066
Medicine 109 5824 5470 61 58 715 38425

Michel Goldman publications per year

The chart shows the history of publications by Michel Goldman between 1970 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michel Goldman published across 56 years, from 1970 to 2025, averaging 13.3 papers a year. Output peaked at 39 publications in 2007. 7 of the 744 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1970 to 2025. Vertical axis: number of publications, 0 to 39. Peak 39 publications in 2007. 1970: 2 publications 1971: 0 publications 1972: 1 publication 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 3 publications 1981: 2 publications 1982: 10 publications 1983: 5 publications 1984: 8 publications 1985: 7 publications 1986: 12 publications 1987: 10 publications 1988: 9 publications 1989: 14 publications 1990: 18 publications 1991: 15 publications 1992: 22 publications 1993: 26 publications 1994: 34 publications 1995: 35 publications 1996: 33 publications 1997: 32 publications 1998: 28 publications 1999: 27 publications 2000: 20 publications 2001: 25 publications 2002: 27 publications 2003: 34 publications 2004: 24 publications 2005: 33 publications 2006: 18 publications 2007: 39 publications 2008: 39 publications 2009: 23 publications 2010: 19 publications 2011: 9 publications 2012: 8 publications 2013: 12 publications 2014: 9 publications 2015: 2 publications 2016: 4 publications 2017: 2 publications 2018: 2 publications 2019: 8 publications 2020: 13 publications 2021: 9 publications 2022: 4 publications 2023: 1 publication 2024: 4 publications 2025: 3 publications
1970 2025

744 publications in total across all disciplines

View publications per year as a table
Michel Goldman: publications per year, 1970 to 2025
Year Publications
1970 2
1971 0
1972 1
1973 0
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 3
1981 2
1982 10
1983 5
1984 8
1985 7
1986 12
1987 10
1988 9
1989 14
1990 18
1991 15
1992 22
1993 26
1994 34
1995 35
1996 33
1997 32
1998 28
1999 27
2000 20
2001 25
2002 27
2003 34
2004 24
2005 33
2006 18
2007 39
2008 39
2009 23
2010 19
2011 9
2012 8
2013 12
2014 9
2015 2
2016 4
2017 2
2018 2
2019 8
2020 13
2021 9
2022 4
2023 1
2024 4
2025 3
Total 744
Download as CSV

Michel Goldman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michel Goldman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 682–691 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 682 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12 682
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Michel Goldman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michel Goldman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 108–109 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 109 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23 109
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award
  • 2023 - Research.com Immunology in Belgium Leader Award
  • 2022 - Research.com Immunology in Belgium Leader Award

Overview

Michel Goldman is affiliated with the Université Libre de Bruxelles in Belgium and has an extensive research portfolio primarily in the field of medicine. Their work spans various subfields including infectious diseases, surgery, neurology, oncology, and molecular biology.

Their main research interests cover topics such as the long-term effects of COVID-19, lymphadenopathy diagnosis and analysis, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, inflammasome and immune disorders, lymphoma diagnosis and treatment, and heparin-induced thrombocytopenia and thrombosis.

Michel Goldman has published recent papers including:

  • "Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies" (2021, Autoimmunity Reviews)
  • "Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report" (2021, Frontiers in Medicine)
  • "Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity" (2021, PLoS Medicine)
  • "Online Information on Probiotics: Does It Match Scientific Evidence?" (2020, Frontiers in Medicine)
  • "Long Covid, a great imitator of the 21th century" (2022, Frontiers in Medicine)

The scientist frequently collaborates with co-authors including Marie Neunez, Serge Goldman, Elie Cogan, Dominique Bron, and Thomas Tousseyn.

Michel Goldman's publications often appear in venues such as Frontiers in Medicine, SSRN Electronic Journal, Frontiers for Young Minds, Autoimmunity Reviews, and PLoS Medicine.

In addition to journal articles, Michel Goldman has authored a book titled Le coronavirus et ces microbes qu'il nous faut combattre, première édition, published by Frontiers Media in 2022.

Best Publications

  • Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

    Bart Keymeulen;Evy Vandemeulebroucke;Anette G. Ziegler;Chantal Mathieu

  • Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

    C. Gérard;C Bruyns;Arnaud Marchant;Daniel Abramowicz

  • Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

    Pervinder Sagoo;Esperanza Perucha;Birgit Sawitzki;Stefan Tomiuk

  • Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

    Fabienne Willems;Arnaud Marchant;Jean-Pierre Delville;Catherine Gérard

  • Interleukin-10 production during septicaemia

    A. Marchant;M. Goldman;J. Devière;B. Byl

  • Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway.

    Valérie Verhasselt;Christel Buelens;Fabienne Willems;Donat De Groote

  • Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients.

    Daniel Abramowicz;Liliane Schandene;Michel Goldman;Alain Crusiaux

  • TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity.

    Michel Goldman;Philippe Druet;Ernst Gleichmann

  • Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

    L. A. B. Joosten;E. Lubberts;P. Durez;M. M. A. Helsen

  • Vaccination and autoimmune disease: what is the evidence?

    David C Wraith;Michel Goldman;Paul-Henri Lambert

  • Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome

    Elie Cogan;Liliane Schandene;Alain Crusiaux;Pascale Cochaux

  • IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection

    Koenraad F. van der Sluijs;Leontine J. R. van Elden;Monique Nijhuis;Rob Schuurman

  • Deficient IL-12(p35) Gene Expression by Dendritic Cells Derived from Neonatal Monocytes

    Stanislas Goriely;Benoı̂t Vincart;Patrick Stordeur;Johan Vekemans

  • Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells.

    Christel Buelens;Fabienne Willems;Anne Delvaux;Géraldine Pierard

  • Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.

    S Dubucquoi;P Desreumaux;A Janin;O Klein

  • Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.

    Arnaud Marchant;Catherine Bruyns;Peter Vandenabeele;Martine Ducarme

  • Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

    S Wadler;E L Schwartz;M Goldman;A Lyver

  • Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

    Hubert Louis;Jean-Luc Van Laethem;Wei Wu;Eric Quertinmont

  • Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor

    Christel Buelens;Valérie Verhasselt;Donat De Groote;Kris M. Thielemans

  • B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

    Liliane Schandené;Cristina Alonso-Vega;Fabienne Willems;C. Gérard

  • Interleukin-10: actions and therapeutic potential.

    Michel Goldman;Thierry Velu;Marina Pretolani

Frequent Co-Authors

Fabienne Willems
Fabienne Willems Université Libre de Bruxelles
Arnaud Marchant
Arnaud Marchant Université Libre de Bruxelles
Stanislas Goriely
Stanislas Goriely Université Libre de Bruxelles
Oberdan Leo
Oberdan Leo Université Libre de Bruxelles
Peter Vandenabeele
Peter Vandenabeele Ghent University
Paul-Henri Lambert
Paul-Henri Lambert University of Geneva
Sandrine Florquin
Sandrine Florquin University of Amsterdam
Kris Thielemans
Kris Thielemans Vrije Universiteit Brussel
Maria-Luisa Alegre
Maria-Luisa Alegre University of Chicago
Muriel Moser
Muriel Moser Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to various related healthcare careers, many of which can be enhanced through online education. For those interested in nursing but coming from non-nursing backgrounds, 12-month accelerated nursing programs online for non nurses provide an excellent pathway to transition quickly into the nursing field while building a strong foundation in patient care and immune system health.

If you're seeking a faster route into registered nursing, exploring 12-month accelerated nursing programs can be beneficial. These programs cater to driven students aiming for rapid completion without compromising essential clinical training relevant to immunology applications.

For those interested in practical nursing roles, easy lpn programs to get into offer accessible entry points. Licensed Practical Nurses often work alongside immunologists in clinical settings, making it a viable pathway to support and understand immune-related healthcare.

Advancing further, easiest nurse practitioner degree programs provide options to gain advanced practice credentials, enabling direct patient diagnosis and treatment in immunology-focused specialties. This pathway is ideal for those looking to deepen their impact on patient immune health.

Best Scientists Citing Michel Goldman

Trending Scientists

Recently Published Articles